A Glimpse of Intellia Therapeutics's Earnings Potential

Intellia Therapeutics NTLA is preparing to release its quarterly earnings on Thursday, 2025-05-08. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Intellia Therapeutics to report an earnings per share (EPS) of $-1.27.

Anticipation surrounds Intellia Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Past Earnings Performance

During the last quarter, the company reported an EPS beat by $0.05, leading to a 7.09% drop in the share price on the subsequent day.

Here's a look at Intellia Therapeutics's past performance and the resulting price change:

Performance of Intellia Therapeutics Shares

Shares of Intellia Therapeutics were trading at $7.25 as of May 06. Over the last 52-week period, shares are down 70.49%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Intellia Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.